‘Rivigo has been able to develop many proprietary solutions that are industry first’
Serving more than 100 clients across segments like E-commerce, white goods, FMCG, auto components and pharma, Rivigo has been…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Strides to sustainabilty
Sustainability, as a concept is gradually gaining traction in Indian Pharma Inc with a growing realisation that it can have a…
Ganymed Pharmaceuticals’ IMAB362 may bring hope for gastric cancer patients: Report
Incidences of the disease are set to increase to over 410,000 by 2024 across US, France, Germany, Italy, Spain, the UK, Japan, and…
A Clash of IPR Cultures
India’s recently released national IPR policy has spurred fresh sparring between various lobbies. As international pressure to…
IPR in the Indo-US pharma trade relationship
India has retained her place on the Priority Watch List of the US TR's Super 301 report. With the Cabinet approving the National…
IPM registers Rs 8449 crs in May 2016
The Odisha market grew the highest followed by Mumbai City Market and Karnataka
PharmaLytica 2016 to be held in Hyderabad
The conference on August 5 and 6, 2016 is likely to see more than 4500 visitors
Redrawing the Lakshman rekha
A national IPR policy, new FDI norms, a possible revamp of the Drugs & Cosmetics Act, Brexit: the pharma sector in India has a…
Express Pharma (Vol.11, No.17) July 1-15, 2016
India's Foremost Pharma & Biotech Magazine
Pharma industry in India to grow to $55 bn by 2020
To be among the top three pharma markets by incremental growth